Article
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis.
Molecular psychiatry - 1 Feb 2006
Muntjewerff J W, Kahn R S, Blom H J, den Heijer M
Abstract excerpt
Elevated plasma homocysteine concentration has been suggested as a risk factor for schizophrenia, but the results of epidemiological studies have been inconsistent. The most extensively studied genetic variant in the homocysteine metabolism is the 677C>T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene, resulting in reduced enzyme activity and, subsequently, in elevated homocysteine. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
